Professional Documents
Culture Documents
Hsri Journal 1 2
Hsri Journal 1 2
2550
/Content
97
98
116
132
145
.. 2547
Elderly Health Problem 2547
4 :
3
Vegetables and Fruit Consumption Patterns among
Thai Population across Four Regions and
the Metropolitan Thailand National Health
Examination Survey III
: 4
156
( 1)
National Multicenter Clinic Research System :
Experience Clinical Research Collaboration
Network - CRCN (Part I)
1
1 2 .. - .. 2550
/Content
168
180
190
193
Northeastern Migrant Labor : Situation
and Health Issues
1 2 .. - .. 2550
97
1 2 .. - .. 2550
.. 2547
*
**
3, ,
, ,
,
(60 ) 19,372
3 .. 2547
51.6, 25.4 14.8
56.8, 81.5 41.2
12.4, 10.3
26.4
80
* (SPICE project)
**
98
Abstract
Key words:
National Health
Examination Survey III, Thai elderly, health status,
chronic diseases, risk
behaviors, treatment
and control
1.7 5 .. 2513
5.8 9.5 .. 2543
.. 2568 ( 18 ) 14.6 21 (1,2)
99
1 2 .. - .. 2550
(3,4)
( 1)
-
-
-
(IHD)
Prediabetic (IGT)
BMI
100
3
(15-59 ) (60 )
(Three-stage stratified probability sampling)
15 - 15 .. 2547
Stata 9.0 19,372
(hemoglobin hematocrit)
(fasting blood sugar) (total cholesterol) (5)
1.
(WHS 2002-2003)(6) 5 (1)
(5)
1-3
2.
( 1)
(ethanol)
8-13 (7)
(1) (2)
/ -. (3) conversion factor
4-5 12 40
(4) (specific density) = 0.79
= ( / / )
101
1 2 .. - .. 2550
1 ()
0
> 0 < 40
> 40 < 60
0
> 0 < 20
> 20 < 40
2 (1) 1
(2)
() (never - smokers) () (ex - smokers)
(8,9)
(physical activity)(10)
3 (1)
(2)
(3)
(1)
(2) (3)
Metabolic
Equivalent Time (MET) (10) 1 MET = 1 kcal/kg/.
102
(1) (2)
(3) (4)
1 6 - 8
1 1 1 4 1
(250 .) 1/2
1
1/2 (1 = 250 . 1 ) 1 1
1/2
()
12 .
3 / 2 = 2
1/2 = 1 = 3
3.
2 (BMI) (waist
circumference) (11,12)
2
(
2)
2 -
- ()
-
-
-
(Central obesity)
(BMI kg/m2)
< 18.5 kg/m2
* 18.5 < 25 kg/m2
> 25 ) 30 kg/m2
> 30 kg/m2
()
* 90
* 80
103
1 2 .. - .. 2550
0.05
.. 2547
1.
60
24.0 37.3
2 ( 3)
1.
/
2.
/
/
3.
/
4.
60-69
(5,323)
13.8
18.0
22.2
28.4
36.6
51.3
19.5
25.8
21.6
29.4
32.0
45.3
49.7
62.0
29.5
39.7
19.9
11.3
26.2
15.3
35.6
23.8
24.0
14.3
31.9
20.0
39.8
23.9
49.6
32.1
37.3
23.2
8.8
9.6
10.3
12.5
14.3
18.3
10.0
11.7
14.8
17.1
18.8
20.3
20.6
21.2
17.0
18.8
4.3
7.3
19.5
7.3
6.3
11.0
22.4
10.4
5.9
8.2
13.3
7.6
10.3
11.9
18.7
12.2
104
2.
50.8 36.3 22.0 70-79 80
18.9, 12.6 10.0 ( 4)
1
( 20 40 ) 6069 5.2 ( 4)
42.6 9
5.5 (60-69 ) 80 ( 5)
10 9
70-79 80
5-6
(5)
90 67
80 2
60-69
70-79
80
49.2
43.0
5.2
2.6
63.7
31.2
2.4
2.7
78.0
18.4
1.0
2.6
5,274
81.1
16.0
1.0
1.9
5,568
105
3,346
87.4
10.5
0.7
1.4
3,546
685
90.0
8.8
0.6
0.6
699
1 2 .. - .. 2550
60-69
70-79
7,301
9,394
9,419
9,068
50.8
44.8
8.5
83.8
36.3
40.8
15.1
87.6
80+
22.0
32.5
33.0
89.6
43.7
42.6
12.7
85.1
3,167
9,931
9,953
9,510
60-69
70-79
80+
18.9
5.5
14.5
82.8
12.6
5.8
28.6
87.6
10.0
3.4
51.7
89.4
16.2
5.5
22.2
85.0
1
12 (13)
5 400 80-90
60-69 70-79 80
99
3.
(14) 140
90
52.2 50.7
60-69
106
60-69
70-79
47.3
20.2
13.8
24.6
52.2
16.1
12.3
36.1
80+
60-69
70-79
80+
59.4
15.8
10.1
51.8
50.7
18.4
12.7
30.4
48.1
32.8
18.9
33.6
54.2
30.3
15.7
42.3
61.8
27.4
9.2
56.1
52.2
31.1
16.1
37.6
51.6
25.4
14.8
36.4
12.7 16.1
60-69 13.8 18.9
10.1 80
80 9.2
(Hct)
(Hb) Hct < 39%, Hb < 13 gm% Hct < 36%, Hb < 12
gm% 30.4 37.6
10 60-69 70-79
80
4.
()
( 7)
107
1 2 .. - .. 2550
(BMI >30 kg/m2)
- 20
-
60-69
70-79
9,366
9,366
9,366
9,419
9,419
2.9
21.1
14.1
81.4
35.7
1.7
16.0
22.6
86.4
38.8
1
10.6
31.6
91.5
42.2
2.3
18.5
18.1
85.2
39.8
9,873
9,873
9,873
9,953
9,953
8.6
47.1
12.1
88.9
43.7
5.4
38.2
19.1
91.1
48.1
2.5
27.8
34
94.1
44.2
7.0
42.5
16.1
90.5
48.4
5,377
5,751
37.1
26.3
49.6
28.4
63.3
34.2
44.5
28.1
5,751
5,751
34.5
26.1
51
28.3
66
26.6
44.7
26.9
80+
60-69
70-79
80+
2.3 7.0
(60-69 ) 2.9 8.6
1 2.5 (80 )
( 7)
18.5 42.5
(< 18.5 kg/mm2)
18.1 16.1
(17,18)
7-8
11
90.5
85.2 5 ( 7)
7 2(17)
(18)
108
60-79
(p > 0.05)
1
60 39.8 48.4
2-3 60
5.
3
4
(1) (2) (3)
(4)
140 90
56.8 ( 50)
80
( 2)
5-6
20-23 26-30 70-79
( 28) 10
15 80 ( 2)
(total cholesterol) 240
80-90
10
10 10
109
1 2 .. - .. 2550
100
90
80
70
60
50
40
30
20
10
0
Fasting Blood Sugar (FBS) 126
41
46.9 37.7
6 27
26
60-69
80 57.1 58.7
5.7
20.9, 22.6 23.4 60-69 70-79
80 30.2, 30.4 20.0
60-69
60-69
29.0 ( 2)
110
3 (1)
(2) (3)
7 10
80 35.6 49.6
50.8 36.3 22.0 70-79 80
18.9, 12.6 10.0 5.2
(60-69 ) 42.6 9 (5.5%)
9-10
5-6
90
2 5
400 80-90
(60-69 )
80
111
1 2 .. - .. 2550
8 9 20
20
20
45 27-28
0.6
(1)
2.3 7.0
(2) 18.1 16.1
(3) 90.5 85.2
7 2(19)
(18)
(1)
50.7 52.2 43.2
10 15 (2)
16 28 81.5
10 (3) 12.7 16.1
2123 20-30
80
(17)
(20,21)
(22)
(23)
(24)
10 26
(25) (
112
) (24,26-29)
(29,30)
(24)
(30)
(17,19)
.. 2548-2550(31)
1. . .. 2513-2543. :
; 2543.
2. , . ..
2543-2568. : ; 2546.
113
1 2 .. - .. 2550
3. . .. 2543: . : ;
2543.
4. , , . : ,
, , , , , .
: .
: ; 2545.
5. . 3 .. 25462547. : ; 2549.
6. World Heath Organization. World Heath Survey 2002-2003. [cited 2007 Jan 15]; Available from: URL: http://www.who.int/
healthinfo/survey
7. Rehm J, Monteiro M, Room R, Gmel G, Jernigan D, Frick U, et al. Alcohol use. In: Ezazati M, Lopez AD, Rogers A,
Murray CJL, editors. Comparative quantitation of health risks, global and regional burden of diseases attributable to
selected major risk factors. Vol. 1. Geneva: WHO 2004. p. 959-1108.
8. Ezaati M, Lopez AD. Smoking and oral tobacco use. In: Ezazati M, Lopez AD, editors. Comparative quantification of
health risks: global and regional burden of disease attributable to selected major risk factors. Vol. 1. Geneva: World
Health Organization; 2004. p. 883-957.
9. Doll R, Peto R. Cigarette smoking bronchial carcinoma dose and time relationships among regular smokers and lifelong
non-smokers. J Epidemiol Community Health 1978; 32:303-13.
10. Bull FC, Armstrong TP, Dixon T, Ham S, Neiman A, Pratt M. Physical inactivity. In: Ezazati M, Lopez AD, Rogers
A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of disease attributable to
selected major risk factors. Vol. 1. Geneva: World Health Organization; 2004. p. 729-882.
11. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on
obesity. Geneva: WHO; 2000.
12. Dobbelsteyn CJ, Joffres MR, Maclean DR, Flowerdew G. A comparative evaluation of waist circumference, waist-to-hip
ratio and body mass index as indicators of cardiovascular risk factors. The Canadian heart health surveys. Int J Obes
Relat Metab Disord 2001; 25(5):652-61.
13. Lock K, Pomerleau J, Causer L, McKee M. Low fruit and vegetable consumption. In: Ezazati M, Lopez AD, Rogers A,
Murray CJL, editors. Comparative quantification of health risks, global and regional burden of disease attributable to
selected major risk factors. Vol. 1. Geneva: WHO, 2004.
14. Lawes CM M, Hoorn SV, Law MR, Elliott P, MacMahon S, Rodgers A. High blood pressure. In: Ezazati M, Lopez AD,
Rogers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of diseases
attributable to selected major risk factors. Vol. 1. Geneva: World Health Organization; 2004.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. [cited 2007 Jan 15]; Available from:
URL :http://care.diabetesjournals.org/cgi/content/full/29/suppl_1/s43
16. World Health Organization. Diabetes mellitus. Sept. 2006. [cited 2007 Jan 15]; Available from: URL: http://www.who.int/
mediacentre/factsheets/fs321/en/index.html
17. . 2 .. 2539-2540.
: ; .
18. Assantachai P, Maranetra N. National survey of the health status and quality of life of the elderly in Thais attending clubs
for elderly. J Med Assoc Thai 2003; 86:938-46.
19. , , , . .
: ; 2542.
20. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the health survey for
England 1998. Hypertension 2001; 38:827-32.
21. Brindel P, Hanon O, Dartigues JF, Ritchie K, Lacombe JM, Ducimetiere P, et al. 3C study investigators. Prevalence,
awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens 2006; 24:29-31.
22. Hypertension Study Group. Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh
and India: a multicentre study. Bull World Health Organ 2001; 79(6):490-500.
23. Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, et al. Prevalence of diabetes and impaired fasting glucose in Korea:
114
24.
25.
26.
27.
28.
29.
30.
31.
Korean National Health and Nutrition Survey 2001. Diabetes Care 2006; 29:226-31.
van Rossum CT, van de Mheen H, Witteman JC, Hofman A, Mackenbach JP, Grobbee DE. Prevalence, treatment, and
control of hypertension by sociodemographic factors among the Dutch elderly. Hypertension 2000; 35:814-21
Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, et al. Prevalence of diabetes and impaired fasting glucose in the
Chinese adult population: international collaborative study of cardiovascular disease in Asia (InterASIA). Diabetologia
2003; 46:1190-8.
Trenkwalder P, Ruland D, Stender M, Gebhard J, Trenkwalder C, Lydtin H, et al. Prevalence, awareness, treatment and
control of hypertension in a population over the age of 65 years: results from the Starnberg Study on Epidemiology of
Parkinsonism and Hypertension in the Elderly (STEPHY). J Hypertens 1994; 12:709-16.
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 19882000. JAMA 2003; 290:199-206.
Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and
impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.
Diabetes Care 2006; 29:1263-8.
Antikainen RL, Moltchanov VA, Chukwuma C Sr, Kuulasmaa KA, Marques-Vidal PM, Sans S, et al. Trends in the
prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil
2006; 13:13-29.
Leino M, Raitakari OT, Porkka KV, Taimela S, Viikari JS. Associations of education with cardiovascular risk factors
in young adults: the cardiovascular risk in young Finns study. Int J Epidemiol 1999; 28:667-75.
. Healthy Thailand 2548-2550. :
; 2548.
115
1 2 .. - .. 2550
4 :
3
*
*
**
*
:
, ,
,
4
3 2546
2547 39,290 * 15
Wilcoxon rank-sum test Kruskal-Wallis test
0.05 5.97 4.56
1.78
( = 1.14), 1.46 ( = 1.00), 3.24 ( = 2.86)
4 (p < 0.05)
26.9, 35.4 26.6
*
**
116
Key words:
vegetables, fruit,
consumption patterns, National
Health Examination Survey
(1-10)
(phytochemicals)
2.7
(11)
(11)
3 2529(12) 4 2538(13)
106 1.33 113 1.42 (
80 1 )(14) 85 1.06
77 0.96
117
1 2 .. - .. 2550
4 4
(validity) (reliability)
( )
(Semi-quantitative food-frequency questionnaire) ()
1 12 /
/ 1
1 1 1
1 1 1
118
6-8 1 1 1
4 1 1 1
(1)
1 1 (2)
1 ( 250 )
.. 2547
KruskalWallis test
4
Wilcoxon rank-sum test 2
Kruskal-Wallis test p < 0.05
() 4
* 5 (15) * 3
* 2
119
1 2 .. - .. 2550
1 39,290
()
6,391 (48.2)
6,458 (51.8)
12,849 (100.0)
4,605 (49.5)
4,772 (50.5)
9,377 (100.0)
4,341 (48.9)
4,605 (51.1)
8,946 (100.0)
2,704
3,074
5,778
()
15-29
30-44
45-59
60-69
70-79
* 80
x
SE
1,255 (9.8)
2,557 (19.9)
2,653 (20.7)
3,739 (29.1)
2,203 (17.1)
442 (3.4)
12,849 (100.0)
40.57
0.253
999 (10.6)
1,895 (20.2)
1,856 (19.8)
2,663 (28.4)
1,592 (17.0)
372 (4.0)
9,377 (100.0)
38.82
0.249
816 (9.1)
1,794 (20.1)
1,799 (20.1)
2,471 (27.6)
1,728 (19.3)
338 (3.8)
8,946 (100.0)
40.96
0.326
680
1,148
1,048
1,566
1,135
201
5,778
(11.8)
(19.9)
(18.1)
(27.1)
(19.6)
(3.5)
(100.0)
39.14
0.517
235 (10.0)
3,985 (10.1)
539 (23.0)
7,933 (20.2)
644 (27.5)
8,000 (20.4)
549 (23.5) 10,988 (28.0)
315 (13.5)
6,973 (17.7)
58 (2.5)
1,411 (3.6)
2,340 (100.0) 39,290 (100.0)
40.19
39.80
0.439
0.150
///
1,496 (11.6)
8,706 (67.8)
2,641 (20.6)
12,843 (100.0)
966 (10.3)
6,500 (69.3)
1,908 (20.4)
9,374 (100.0)
898 (10.0)
6,116 (68.4)
1,928 (21.6)
8,942 (100.0)
664
3,902
1,177
5,743
(11.6)
(67.9)
(20.5)
(100.0)
385 (16.5)
1,555 (66.5)
398 (17.0)
2,338 (100.0)
4,409 (11.2)
26,779 (68.3)
8,052 (20.5)
39,240 (100.0)
12,569 (97.9)
101 (0.8)
173 (1.3)
12,843 (100.0)
9,255 (98.8)
103 (1.1)
5 (0.1)
9,363 (100.0)
8,837 (98.9)
76 (0.8)
25 (0.3)
8,938 (100.0)
5,160
16
562
5,738
37,988 (96.9)
328 (0.8)
903 (2.3)
39,219 (100.0)
1,157 (9.1)
8,819 (69.0)
2,254 (17.6)
546 (4.3)
12,776 (100.0)
563 (6.1)
6,691 (72.1)
1,527 (16.5)
495 (5.3)
9,276 (100.0)
1,369 (15.4)
5,692 (63.8)
1,424 (16.0)
429 (4.8)
8,914 (100.0)
559
3,629
1,136
401
5,725
(9.8)
(63.4)
(19.8)
(7.0)
(100.0)
3,822 (9.8)
26,118 (66.9)
6,945 (17.8)
2,135 (5.5)
39,020 (100.0)
120
174 (7.5)
1,287 (55.3)
604 (25.9)
264 (11.3)
2,329 (100.0)
18,934 (48.2)
20,356 (51.8)
39,290 (100.0)
1 () 39,290
320 (4.3)
3,138 (42.1)
123 (2.8)
1,646 (37.7)
1,586
365
38
582
(21.3)
(4.9)
(0.5)
(7.8)
53 (0.7)
1,374 (18.4)
7,456 (100.0)
650
339
29
808
(14.9)
(7.7)
(0.7)
(18.5)
56 (1.3)
716 (16.4)
4,367 (100.0)
()
204 (4.3)
1,766 (37.1)
990
280
34
656
(20.8)
(5.9)
(0.7)
(13.8)
65 (1.3)
769 (16.1)
4,764 (100.0)
99 (3.0)
1,116 (33.5)
415
241
6
59
(12.4)
(7.2)
(0.2)
(1.8)
37 (3.2)
492 (42.4)
783 (3.7)
8,158 (38.7)
400
91
19
21
4,041
1,316
126
2,126
(34.5)
(7.9)
(1.6)
(1.8)
(19.2)
(6.2)
(0.6)
(10.1)
7 (0.2)
1,390 (41.7)
3,333 (100.0)
9 (0.8)
91 (7.8)
1,160 (100.0)
190 (0.9)
4,340 (20.6)
21,080 (100.0)
< 10,000
6,784 (52.9)
10,000-24,999
4,120 (32.1)
25,000-49,999
940 (7.3)
> 50,000
367 (2.9)
613 (4.8)
12,824 (100.0)
x
13,998.30
SE
911.462
2,535 (44.2)
1,347 (23.5)
284 (5.0)
108 (1.9)
1,459 (25.4)
5,733 (100.0)
11,190.82
586.138
615 (26.3)
783 (33.5)
317 (13.6)
205 (8.8)
416 (17.8)
2,336 (100.0)
23,305.03
1,633.606
23,315 (59.5)
9,163 (23.4)
2,345 (6.0)
987 (2.5)
3,382 (8.6)
39,192 (100.0)
10,175.66
400.094
4,651 (49.6)
4,726 (50.4)
9,377 (100.0)
2,743 (47.5)
3,035 (52.5)
5,778 (100.0)
2,340 (100.0)
0 (0.0)
2,340 (100.0)
20,617 (52.5)
18,673 (47.5)
39,290 (100.0)
6,453 (50.2)
6,396 (49.8)
12,849 (100.0)
4,430 (49.5)
4,516 (50.5)
8,946 (100.0)
10,176
23,305 ,
121
1 2 .. - .. 2550
5.971.699 ( 1)
70
( 2)
7
6
5
5.84 5.8
5.77
6.06
5.95
4
3
:
4
(p-value < 0.05)
2
1
0
../.
1
80.0
70.0
60.0
50.0
40.0
30.0
20.0
10.0
0.0
3
4
5
122
()
4.562.166
3 40
( 4)
( 3)
6
4.71
4.57 4.71
4.43
4.35 4.71
3.99
4.94 5.04
4.41 5.1
4.12
4
(p < 0.05)
2
1
0
4.79
../.
3
45
40
35
30
25
20
15
10
5
0
4
5
123
1 2 .. - .. 2550
4
(p < 0.05)
2 (Mean) (Standard deviation; SD) (Median)
1.781.298 (Median = 1.14)
(* 3 )
(Mean = 1.891.314; Median = 1.71)
4
(Mean = 2.251.494; Median = 2.00)
4 (p < 0.05)
1.461.245 (Median = 1.00)
(* 2 )
4 1.661.193 (Median = 1.43) 1.191.091 (Median =
0.86) 4
(p < 0.05)
3.242.079 (median = 2.86) * 5
(mean = 3.362.205; median =
2.86) (mean = 2.831.847; median
= 2.29)
(mean = 4.03; SD = 2.442; median = 3.71)
4 (p < 0.05)
, ,
1 4 * 3
( 3) 4
( 41.0)
124
125
a,b,c,d
(Median) (p<0.05)
(Median) (p<0.05)
1,2,3,4,5
(Median) (p<0.05)
: [(A,B,C,D,E), (a,b,c,d), (1,2,3,4,5)] (Median)
(p<0.05)
A,B,C,D,E
5,799 5,731 11,530 4,367 4,350 8,717 4,023 4,108 8,131 2,578 2,807 5,385 2,220 35,983
3.44 3.28
3.36
2.90
2.76
2.83
3.42
3.18
3.30
3.20
3.20
3.20
4.03
3.24
2.246 2.161
2.205 1.853 1.839 1.847 2.178 1.998 2.092 1.727 1.898 1.818 2.442 2.079
A
a
2.861 2.43B 2.14b 2.292 3.00A,C 2.71a,c 2.861,3 3.00A,C,D 2.86a,c,d 3.001,3,4 3.71E,5 2.86
3.00 2.86
n
Mean
SD
Median
5,999 5,900 11,899 4,454 4,456 8,910 4,121 4,203 8,324 2,635 2,888 5,523 2,268 36,924
1.60 1.50
1.55
1.28
1.09
1.19
1.53
1.30
1.41
1.68
1.64
1.66
1.78
1.46
1.338 1.297
1.319 1.113 1.059 1.091 1.282 1.170 1.232 1.154 1.227 1.193 1.360 1.245
A
a
1.001 1.00B 0.86b 0.862 1.00C 1.00c 1.003 1.43D 1.29d 1.434 1.43D,E,5 1.00
1.14 1.00
n
Mean
SD
Median
6,124 6,069 12,193 4,526 4,580 9,106 4,223 4,345 8,568 2,655 2,907 5,562 2,279 37,708
1.85 1.79
1.82
1.63
1.66
1.64
1.90
1.88
1.89
1.51
1.57
1.54
2.25
1.78
1.396 1.354
1.375 1.153 1.207 1.180 1.334 1.294 1.314 1.013 1.179 1.103 1.494 1.298
A
a
1.291 1.00B 1.00b 1.002 1.71C 1.71c 1.713 1.00D 1.00d 1.004 2.00E,5 1.14
1.43 1.29
n
Mean
SD
Median
2 () 39,290
4,662 4,696 9,358 3,775 3,687 7,462 3,202 3,275 6,477 2,269 2,409 4,678 1,433 29,408
(67.1) (71.4) (70.0) (79.5) (75.8) (76.4) (70.3) (71.4) (71.2) (80.5) (76.8) (77.6) (59.0) (73.1)
1,791 1,700 3,491
876 1,039 1,915 1,228 1,241 2,469
474
626 1,100
907 9,882
(32.9) (28.6) (30.0) (20.5) (24.2) (23.6) (29.7) (28.6) (28.8) (19.5) (23.2) (22.4) (41.0) (26.9)
126
* (Being weighted)
(/)
<5
4,499 4,594 9,093 3,748 3,806 7,554 3,151 3,350 6,501 2,080 2,256 4,336 1,492 28,976
(64.8) (70.5) (68.7) (78.5) (79.7) (79.6) (67.9) (72.2) (71.4) (73.5) (72.2) (72.5) (63.5) (73.4)
*5
1,954 1,802 3,756
903
920 1,823 1,279 1,166 2,445
663
779 1,442
848 10,314
(35.2) (29.5) (31.3) (21.5) (20.3) (20.4) (32.1) (27.8) (28.6) (26.5) (27.8) (27.5) (36.5) (26.6)
(/)
<2
3,766 4,033 7,799 3,297 3,606 6,903 2,728 3,141 5,869 1,494 1,787 3,281 1,289 25,141
(54.8) (61.1) (59.0) (69.3) (73.7) (73.0) (58.2) (66.4) (64.8) (52.9) (55.9) (55.1) (57.2) (64.6)
*2
2,687 2,363 5,050 1,354 1,120 2,474 1,702 1,375 3,077 1,249 1,248 2,497 1,051 14,149
(45.2) (38.9) (41.0) (30.7) (26.3) (27.0) (41.8) (33.6) (35.2) (47.1) (44.1) (44.9) (42.8) (35.4)
(/)
<3
()
3 *
1 2 .. - .. 2550
1 3 * 2
( 44.9)
5
1 4 ( 26.6)
( 36.5)
5
1.1,
1.2, 1.2
50
40
30
41.3
29.5
26.1 26.9
33.4 35.4
30.9
25.1 26.6
20
10
0
( 4)
( 34.9, 73.2, 48.2 ) (
9.1, 17.1, 15.0, )
15
2 3
10,176 2 3
127
1 2 .. - .. 2550
) 6
7
(/)
<3
*3
90.9
9.1
12,931
65.1
34.9
26,359
(/)
<2
*2
82.9
17.1
25,453
26.8
73.2
13,837
(/)
<5
*5
85.0
15.0
10,492
51.8
48.2
11,398
(weight)
3 .. 2529(12) 4 .. 2538(13)
.. 2529
1.33, 1.06, 2.40 (12) .. 2538 1.42,
0.96 2.38 (13) 5
.. 2546(16) 24
128
0.28, 0.88,
1.16
(semiquantitative food-frequency questionnaire)
1
1.78, 1.46 3.24
4
5.97 4.56
1 ( 70)
4
(vegetables
and fruit availability)
( 27)
Joshipura (1)
(coronary heart disease)
126,399 The Nurses Health Study The
Health Professionals Follow-Up Study 1
4
5 12(2)
129
1 2 .. - .. 2550
1. Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rlmm EB, Spelzer FE, et al. The effect of fruit and vegetable intake
on risk for coronary heart disease. Ann Intern Med 2001; 134: 1106-14.
2. Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, et al. Fruit and vegetable intake and risk of
major chronic disease. J Natl Cancer Inst 2004; 96: 1577-84.
3. Djousse L, Arnett DK, Coon H, Province MA, Moore LL, Ellison RC. Fruit and vegetable consumption and LDL
cholesterol: the National Heart, Lung, and Blood Institute Family Heart study. Am J Clin Nutr 2004; 79: 213-7.
4. Pavia M, Pileggi C, Nobile CGA, Angwlillo IF. Association between fruit and vegetable consumption and oral cancer:
a meta-analysis of observational studies. Am J Clin Nutr 2006; 83: 1126-34.
5. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, et al. Associations between breast cancer
risk and catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005; 162: 943-52.
6. Michels KB, Giovannucci E, Chan AT, Singhania R, Fuchs CS, Willett WC. Fruit and vegetable consumption and
colorectal adenomas in the Nurses Health Study. Cancer Res 2006; 66: 3942-53.
7. Genkinger JM, Platz EA, Hoffman SC, Comstock GW, Helzlsouer KJ. Fruit, vegetable, and antioxidant intake and allcause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland.
Am J Epidemiol 2004; 160: 1223-33.
8. Hertog MGL, Bueno-de-Mesquita H, Fehily AM, Sweetnam PM, Elwood PC, Kromhout D. Fruit and vegetable
consumption and cancer mortality in the Caerphilly study. Ca Epidemiol Biomark & Prev 1996; 5: 673-7.
9. Christen WG, Liu S, Schaumberg DA, Buring JE. Fruit and vegetable intake and the risk of cataract in women. Am J
Clin Nutr 2005; 81: 1417-22.
10. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable
intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 1999; 69: 727-36.
11. World Health Organization. The world health report 2002: Reducing risks, promoting healthy life. Geneva: World Health
Organization; 2002.
12. Nutrition division department of Health Ministry of Public Health, School of Public Health Mahidol University. The third
national nutrition survey of Thailand, 1986. Bangkok: The War Veterans Organization of Thailand; 1995.
13. . 4 .. 2538.
: ; 2538.
14. Lock K, Pomerleau I, Causer L, et al. Low fruit and vegetable consumption In: Ezzati M, editors. Comparative
quantification of health risks, global and regional burden of disease attributable to selected major risk factors. Geneva:
WHO; 2004.
130
15. World Health Organization. Fruit and vegetable promotion initiative: a meeting report. WHO Fruit and Vegetable
Initiative Expert Meeting; 25-27 August 2003; Geneva. Swisszerland: World Health Organization; 2003.
16. . 5
.. 2546. : ; 2549.
131
1 2 .. - .. 2550
: 4
*
#
/
4
44 1 ..2547 ..2548
(30 ) 30
(60 ) 9 ( 90 ) 5
/ 106 (
25 - 333 ) 20 ( 45.5)
100 95
35 ( 4 -
80 ) 1
Population Council
132
:
, ,
,
,
Abstract
50
1 13 ( 29.5)
1
/
Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand,
Department of Psychiatric Nursing, Faculty of Nursing, Chiang Mai University, Chiang Mai,
Thailand,
#
Population Council, Bangkok, Thailand
Key words :
HIV, AIDS, Anti
Retroviral Therapy
(ART), ARTS clinic,
health personnel
133
1 2 .. - .. 2550
134
1.
44 15 13
*
10
Horizons Program, The Population Council
135
1 2 .. - .. 2550
(%)
30
60
90 - 150
9
7
10
4
30 (68.2)
3
4
1
1
9 (20.5)
3
2
5 (11.4)
15
13
11
5
44
11 5 (30 )
68.2 (60 ) 20.5 (90 ) 11.4 ( 1)
2.
(93.2 %) /
2
150 1
2 /
3.
41
2
1
2 ( 2)
136
30
60
90 - 150
(n = 28*)
(n = 9)
(n = 4)
3 1 .
1
6
2
3
5
4
9
3
8
2
2
-
1
1
6
1
-
1
1
1
1
5
10
3
14
2
3
3
1
* 2
30
60
90
SD
SD
SD
SD
( - )
( - )
( - )
( - )
83.9 40.2
(25 - 206)
36.5 16.3
(10 - 80)
39.0 22.7
(10 - 100)
SD = Standard deviation
137
100.6 43.2
(46 - 165)
34.4 12.9
(15 - 50)
63.5 40.1
(15 - 120)
250.0 95.6
(95 - 333)
32.2 17.6
(11 - 50)
106.0 56.4
(50 - 200)
106.2 71.0
35.6 15.5
51.3 37.7
1 2 .. - .. 2550
4.
80
1-2 1
73.3 1-2 76.6
1-3
55.5
1-2 1-2
4
/
44
/
60
22.2 26.7 1
2-3 46.7 44.5
20.0
6 16.6 ( 4)
83.7
1 9.3 2
138
(%)
30
60
90
8 (26.7)
19 (63.3)
3 (10.0)
4 (44.5)
3 (33.3)
2 (22.2)
1 (20.0)
3 (60.0)
1 (20.0)
7 (23.3)
18 (60.0)
5 (16.7)
4 (44.5)
3 (33.3)
2 (22.2)
1 (20.0)
4 (80.0)
-
8
14
3
5
2 (22.2)
4 (44.5)
3 (33.3)
-
3 (60.0)
1 (20.0)
1 (20.0)
-
1
2
1
2-3
1
2-3
4-5
6-10
(26.7)
(46.7)
(10.0)
(16.6)
5. /
//
24.6 17.5 5.4
/
3
6.
(Global Fund)
5.7 6.7 9.6
7.
/ 80
139
1 2 .. - .. 2550
19 (43%) 27 (61%)
8.
-
-
-
/
1)
2)
3) //
4)
5)
3-4
/
(5-6)
/ 3-4
140
.. 2548
NAPHA 73,507 10
( 6 ) 10,377 (14%)
.. 2545
3-4 3-4 (7)
(8)
90
1 5-10
141
1 2 .. - .. 2550
/
/(9)
/ 1
1 4 /
3
(10)
80
/
(11)
/
142
/ 1
/
4
44
143
1 2 .. - .. 2550
1. Global situation of the HIV/AIDS epidemic, end 2004. Wkly Epidemiol Rec 2004; 79(50):441-9.
2. . :
. : ; 2548.
3. World Health Organization. The WHO strategy : treating 3 million by 2005 : making it happen. France: 2003.
p. 9-11.
4. . . 2548; 6:214-6.
5. Chequer P, Hearst N, Hudes E, Castilho E, Rutherford G, Loures L, et al. Determinants of survival in adult
Brazilian AIDS patients, 1982-1989. AIDS 1992; 6:483-7.
6. , , , , ,
. CD4 200 cell/mm3
. 2548; 31:184-92.
7. ARV NAPHA 2548. [online] 2007 [cited 2007
Mar 24]. Available from URL: http://www3.easywebtime.com/demo010/chart1.htm
8. , , , .
50,000
. 2548; 17:129-46.
9. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians experience with the
acquired immunodeficiency syndrome as a factor in patients survival. N Engl J Med 1996; 334:701-6.
10. , , , .
(PCU)
6 . 6 2548; 2(1): 82-97.
11. , .
. 2004;
13: 632-41.
144
1 2 .. - .. 2550
:
,
,
\
2547 2550
2547 2549 5,460
1,730 2,513
22 (.) 31
.
* ,
145
Abstract
1 2 .. - .. 2550
Key words:
crisis, health system, southern provinces
The violence in the Southern provinces in Thailand took a toll on physical, psycho-social and spiritual health. Data collection began from March 2004
to March 2007 using questionnaires, face to face interview including group seminars and brainstorming sessions. It was found that the frequency of chaotic events
occured 5,460 times during January 2003 to August 2006. About 1,730 have been
killed and 2,513 injured. These victims included 22 health workers and 31 health
volunteers.
In the prime of the violence, every single hospital has prepared itself to be
ready to cope with those crises. Health workers, for example, suddenly changed
their behaviors substantially such as adjusting their work schedules, not
wearing uniform, taking more precautions, decreasing or avoiding their proactive roles in field works, particularly health promotion and health prevention.
These were remarkable changes in health care roles which would have long term
serious effects on the communitiy health. In addition, security in hospitals has
been tightened while stocks of food became critically necessary. Some local health
offices rearranged their teams by having village health volunteers working closely
with their health officers. These actions could boost their morale and ensure
their safety. Community faith in them and being natives inspired health workers
to remain in their posts.
It was interesting that the number of cases of out-patient and in-patient
departments had not changed much but the number of patients visiting local
health offices clearly decreased. Nevertheless, the number of patients in labor
departments increased and the chronic disease cases increased as well. Besides,
the number of cases with psychosis or having mental problems sharply increased.
Eventhough, the turn over and replacement of health workers became even but
the lack of medical specialists in some areas remained. Number of registered
nurses would become the major concern in the near future if the violence is not
restrained.
The crisis dictates requirements on short-term measures to focus on security, life protection, creating the supporting systems about counseling, referring,
transferring and maintaining the systems. In the long run, measures include
peace restoration, then, create health participatory system of people in communities, self-care system and enhance effectiveness of health system. It should be
concerned about the opportunity to build Muslim medical curriculum and
agenda. Having a specific team work to monitor the situation closely, connecting and communicating with the government and developing the participatory
management of data system and solving the problem may gradually decrease
the violence. In addition, research and development on the consequences of the
health system of the restive southern provinces are required in order to cope
with the drastic change.
146
2547- 2550
(Intellectual Deep South Watch)
(.)
(
) 1 4 27
2 - 2547
3
12-15 1 12
- 2547
.. 2547
147
1 2 .. - .. 2550
1. : (1)
32 .. 2547 .. 2549
5,460 2,074 1,656 1,412
318
32
1,730 2,513
4,243 1
350
316
300
200
211
198
150
100
50
0
134
87
41
91
180
92
56
90
129
77
134
114
165
145 157
173
171
131
125
100
99
116
152
131
146
124
131
91
38
. 47
. 47
. 47
. 47
. 47
. 47
. 47
. 47
. 47
. 47
. 47
. 47
. 48
. 48
. 48
. 48
. 48
. 48
. 48
. 48
. 48
. 48
. 48
. 48
. 49
. 49
. 49
. 49
. 49
. 49
. 49
. 49
250
1 2547 2549
(2) 5,381
1
(3) 2549
22 31 ( 2)
148
1 (
)
..
2545
2546
2547
2548
2549
2550
6
35
869
1,087
1,114
69
3,180
13
36
435
893
689
25
2,091
1
0
44
23
42
0
110
20
71
1,348
2,003
1,845
94
5,381
: 20 2550
2
:
5 .
5
4
4
2
15
4
1
2
0
7
3
1
4
0
8
9
3
11
0
23
: 2549
2. (4)
8.00-16.00 .
149
1 2 .. - .. 2550
(service mind) exit nurse
.
3.
3 (4)
(refer case)
150
/
70.0
60.0
60.0
55.0
50.0
25.0
18.00 .
(5)
2549
( 3)
3.42 2545 3.26 2547
151
1 2 .. - .. 2550
72
23
51
786
5
2
1
5
2
1
2
30
63
20
48
751
80
16
42
737
13
8
5
5
59
11
36
737
101
41
67
243
16
2
3
2
1
84
41
63
239
: 1) 2
1/2549
2)
2.1
2.2 2
4.
(crisis management)
152
(recruitment) (GIS)
-
-
- /
-
(on the job training)
-
153
1 2 .. - .. 2550
5.
Crisis Forum
1. . 32 . :
; 2549.
2. . . :
; 2550.
154
3. . :
. 30 2549
. : ; 2549.
4. , , . 3
. : ; 2548.
5. . :
2 2/2550 11 2550;
. : ; 2550.
6. . 3 . :
; 2549.
155
1 2 .. - .. 2550
:
( 1)
*
*
*
*
*
;
,
,
,
,
,
156
Abstract
Key words:
multi-center study,
clinical research,
collaborative research, outcome research, research
management, research network
Thailand has been facing a crucial situation of insufficient support on research work especially those for health care services or clinics. This results in the
high expenditure of the nation on curing and nursing with significant incremental rate year on year. In order to maximize the effectiveness of health care with
less spending and improve the capability of clinical research leading to the self
reliance on the national medical system, Clinical Research Collaboration Network (CRCN) or the research network of the Consortium of Thai Medical Schools
and Health System Research Institute - HSRI, was established. With the objective to facilitate the multicenter clinical research projects, the network has been
promoting the joint venture in research investment and encouraging healthy relationship among investigators by having pre-agreements on governance, data
ownership and authorship issues, and the scope of responsibility and authority
of each member of the team.
The research topics are primarily driven by clinical experts main interest
which is based on direct working experiences. In order to lessen the collaborative burden and difficulties, CRCN encourages investigators to conduct a simple
design study, for example, Disease Registry, and focuses substantially on the
data quality assurance and team building. As a result, the team spirit of the team
members is also enriched and strengthened, in addition to the improvement of
data quality control.
Moreover, the collaborative research management capacities are also enhanced as more research management team is built; data management unit is
constantly improved in data management and statistical analysis skills, working
through on-going projects. Networking of data management and statistical analysis was established, a memorandum of understanding was signed with the University of North Carolina. Subsequently, data management experts have regular
communication with Thai counterparts and visited the sites of the CRCN projects
annually to help in the areas of local data management and capacity development on statistics. This also led to quality assurance of multicenter clinical research conducted locally.
The CRCN experiences, will serve as the convincing examples and foundation for the more sophisticated new or extended multicenter clinical research
projects, especially the clinical trials on new local medical products and searching for new clinical investigative tools to improve health under the local Thai
context in the future.
200,000 3
2546 6.5 5
2 30,000 (1)
157
1 2 .. - .. 2550
(WHO-GCP ICH-GCP)(2)
(National Clinical Research Enterprise, NCRE)(3)
National Institute of Health (4), UK Clinical
Research Collaboration (CRC)(5)
(6)
International
Health Research Awards 2543
(Collaborative Research Coordination Network)
(Clinical Research Collaboration Network: CRCN)
(Clini-
158
1.
1.1
(7)
0.57 10.20
(8)
(.)
(.)
(9%) (9%) (10%) (7%)(7)
1.2
1.2.1
1.2.2
1.2.3
4
159
1 2 .. - .. 2550
(clinical trial)
1.2.4
1.3
1.3.1
Population Health Research Institution, McMaster University, Hamilton, Canada
2
1.3.2
University
of North Carolina 2549
1.3.3 Thailand Center of Excellence in Life Sciences
(TCELS) postdoctoral fellow (.. 2550)
1.3.4 (TCELS)
contract research organization (business unit)
1.3.5
(Forum for Ethical Review Committees in
160
1.4
1.4.1
1.4.2
1.4.3
1.4.4
2.
( 1)
3.
2
(monitor) (audit)
161
1 2 .. - .. 2550
clinical trial
3-4
ICH-GCP
(monitoring)
CRCN
(clinical indicator)
3
162
1 ()
Data Management and Biostatistics Network (DMBN)
DMBN
-
guide line ICH/GCP
Clinical Research
-
(criti-
cal mass) DMBN
e-Journal
-
DMBN
(Prof.
Shrikant Bangdiwala)
University of North Carolina
CRCN
163
1 2 .. - .. 2550
3.1
3.1.1
Good Clinical Practice (GCP)
3.1.2
(sponsor)
Standard Operating Procedure (SOP) GCP
3.1.3 CRCN
(blinding)
GCP
3.1.4 CRCN
3.1.5
CRCN
3.1.6
CRCN
164
CRCN
3.2 (audit)
3.2.1
GCP
3.2.2
CRCN
3.2.3 CRCN
CRCN
3.3
CRCN
CRCN
CRCN CRCN
165
1 2 .. - .. 2550
1. . 28 2549 5
2549 2549 [ 4 . 2549]; : URL: http/www.fda.moph.go.th/news/
news2849.html
2. World Health Organization. Guidelines for Good Clinical Practice for Trials on Pharmaceutical Products: WHO technical
report series, No. 850. Geneva: WHO; 1995.
3. Crowley W. Clinical research in the United States at a crossroads: proposal for a novel public prevate partnership to
166
4.
5.
6.
7.
8.
9.
167
1 2 .. - .. 2550
:
, ,
,
,
,
,
41
26 3 2550
3.5 - 8.4
(micro vascular complications)
50
(retinopathy) 10-29
(proteinuria) 10-36 (neuropathy) 9
(macro vascular complications)
2
58
43.9
42.8 30.7
8.1 4.4
2
(myocardial infarction) (ischemic heart disease)
2
* ,
168
Abstract
Key words:
chronic diseases,
diabetes, prevention and control
framework, screening, change of life
style, complications, national
policy
(1)
169
1 2 .. - .. 2550
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80 +
0.6
0.8
0.7
1.1
0.6
1.8
3.1
3.1
4.8
4.1
4.3
4.2
2
0.1
0.3
1.1
1.5
1.2
2.4
5
5.8
7.8
4.4
6.8
5.5
2.8
4.4
NA
NA
1.6
5.2
5.1
11.4
12.6
13.8
18.9
12.3
10.1
6.4
15.7
9.2
7.3
3 .. 2546 - 2547
6.4 7.3 50-69 13.8
18.9 (2) ( 1)(2-4)
41 26 (2)
30-50 (5)
1 2539 7,702
- 18,724 (6) 3 2550
170
50 3.5 - 8.4
1.4 - 2.1
.. 2547
2.7 Disabilities-Adjusted Life Years (DALYs) 100,000 1.8
DALYs 100,000
( 2)(7)
(micro vascular complications) 50
(retinopathy) 10-29
(proteinuria) 10-36 (neuropathy) 9(5)
(macrovascular complications)
2
(8,9)
(life style intervention) 7
150 5
2 .. 2542 2547 ( DALYS 100,000 )
1
2
3
4
5
6
7
8
9
10
2542
2547
9.6
5.1
2.7
1.3
2.5
1.6
1.6
1.7
1.2
1.0
6.4
5.8
3.3
3.3
2.8
1.9
1.8
1.8
1.4
1.4
2547(7)
2547
171
2542
2547
2.8
3.7
2.7
1.5
1.1
1.1
1.2
1.2
0.9
1.0
3.1
2.9
2.7
1.9
1.4
1.2
1.2
1.2
1.2
1.1
1 2 .. - .. 2550
58 metformin
31(10)
(11)
.. 2547
7 15
(7) ( 1)
- BMI 27.5 ( 3.4 ) (
2.9 ) ( 1.9 ) 50 ( 1.8 ) ( 1.7
) ( 1.5 )(9)
(2)
31.4 2(12)
()
()
()
0.5
0.3
0.3
0.2
0.9
0.9
1.3
1.7
2.2
3.8
4.6
5.8
5.6
8.1
.. 2547(7)
1 .. 2547
172
9.5
: 11 .. 2546
2 (13) (n = 9,419)
27.0 18.7
10.5 14.2 (12)
43.9 42.8 30.7
8.1 4.4 (13) ( 2)
3 .. 2531-2545 (n = 1,502)(14)
318
200
86
69
58
51
45
40
29
18
35
22
9
8
6
6
5
4
3
1
173
1 2 .. - .. 2550
4 .. 2531-2545 (n = 83,489)(14)
20,785
11,416
7,197
2,710
2,670
2,093
1,867
1,692
1,453
1,376
42
23
14
5
5
4
4
3
3
3
3 .. 2536
174
2 HbA1c 9.2 7.7
3
4
-
-
-
6 (16)
1.
2.
3.
4.
5.
6.
175
1 2 .. - .. 2550
4.
5.
6.
7.
8.
9.
10.
11.
12.
.
.
.
176
12
4.
5.
177
1 2 .. - .. 2550
1.
2.
3.
4.
5.
6.
7. .. 2546
(Bangkok Charter)(20)
..
1. Chronic Disease Epidemiology, 2nd ed. USA: American Public Health Association; 1998.
2. , , .
3 .. 2546-2547 . : ; 2550.
178
3. , . 1
.. 2534 - 2535. : ; 2539.
4. , . 2
.. 2539 - 2540. : ; 2541.
5. Lawrence J, Robinson A. Screening for diabetes in general practice. Prev Cardiol 2003; 6: 78-84.
6. .
. : ; 2541.
7. . 2547. :
; 2550.
8. , . : 2.
2550; 23(5): 1-9.
9. Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, et al. A risk score for predicting
incident diabetes in the Thai Population. Diabetes Care 2006; 29(8): 1872-7.
10. Knowler WC, Barrett - Connor E, Fowler SE, Hammon RF, Lachin JM, Walker EM, et al. (Diabetes Prevention Program
Research Group). Reduction in the incidence of type 2 diabetes with life style intervention or metformin. N Engl J Med
2002; 346: 393-403.
11. Goyder E, Irwig L. Screening for diabetes: what are we really doing? BMJ 1998; 317: 1644-6.
12. Chetthakul T, Deerochanawong C, Suwanwalaikorn S, Kosachunhanun N, Ngarmukos C, Rawdaree P, et al. Thailand
diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus. J Med
Assoc Thai 2006; 89 (Suppl 1): S27-36.
13. Rawdaree P, Ngarmukos C, Deerochanawong C, Suwanwalaikorn S, Chetthakul T, Krittiyawong S, et al. Thailand
diabetes registry (TDR) project: clinical status and long term vascular complications in diabetic patients. J Med Assoc
Thai 2006; 89 (Suppl 1): S1-9.
14. Marja N, Klas W. Prevalence and variation in quality of care. Diabetes in Finland. [online] 2007. [cited 2007 July 7];
available from: URL: http://www.diabetes.fi/ tiedoston_katsominen.php?dok_id=534
15. Murphy D, Chapel T, Clark C. Moving diabetes care from science to practice: the evolution of the National Diabetes
Prevention and Control Program. Ann In Med 2004; 140(11): 978-84.
16. Stewart P, Douglas Consulting. Building a national diabetes strategy: a strategic framework. Volume 2. [online] 2007.
[cited 2007 May 25]; available from: URL: http://www.phac-aspc.gc.ca
17. Robert S. Improving diabetes services - the NSF two years on. [online] 2007. [cited 2007 July 7]; available from: URL:
http://www.dh.gov.uk/prod_consum_dh/groups/ dh_digitalassets/@dh/@en/documents/digitalasset/dh_4106720.pdf
18. Etu - Seppl L, Ilame - Parikha P, Haapa E, Martlila J, Korkee S, Sampo T. Programme for the prevention of type 2
diabetes in Finland 2003 - 2010. [online] 2007. [cited 2007 July 7]; available from : URL : http://www.diabetes.fi/
tiedoston_katsominen.php/?dok_id=179
19. Australian Health Ministers Conference. National Service Improvement Framework for Diabetes. [online] 2007. [cited
2007 July 7]; available from: URL: www.health.gov.au/chronicdiseasestrategy
20. The Bangkok Charter for Health Promotion in a Globalized World 2005. [online] 2007. [cited 2007 July 7]; available
from: URL: http://www.who.int/healthpromotion/ conferences/6gchp/bangkok_charter/en/print.html
179
1 2 .. - .. 2550
*
*
:
,
, ,
,
Abstract
Key words :
second opinion, system, mechanism,
health information,
access
180
(second opinion)
1.
1970
(1)
Second Surgical Opinion Program
(SSOP) mandatory SSOP
Mandatory SSOP
clinical guideline objective evidence
- (prove or disprove)
-
(best option)
181
1 2 .. - .. 2550
-
- (claim)
- (efficiency)
- (American Medical Association)
Gray B. (trust)
(2)
2. (3)
(1) (uncertain diagnosis)
(2) (life-threatening)
(3) (controversial) (experimental) (risky)
(4) (treatment not working)
182
(5)
(2)
(3)
(4)
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(clinical trial)
3.
(1) - (cost benefit) McCarthy EG (6)
$1.00 mandatory SSOP $2.63
McSherry CK (7) -
mandatory SSOP 1.34
(2) (therapeutic advice) 71
(diagnosis)
10
Mustafa MK (8)
(3) caesarean delivery 7 intrapartum caesarean
delivery 13 maternal/perinatal morbidity mortality 149,276
36 (9)
Newhouse JP Lindsey P(10)
utilization cost benefit
(error percentage)
183
1 2 .. - .. 2550
4.
(1)
(11)
(2)
(11)
(3) on-line consultation e-consultation
on-line consultant
(11)
(4)
-
-
(physical examination) (medical record)
(12)
184
5.
cyberspace
(13)
(
18 ) 97 2001 1998 54 (14) Fox
S.(15) 8 10 79
66 51
( 1) 5
1 3 7
1
( : )
2002
2004
, , *
*
*
*
*
,
*
(Medicare or Medicaid)
63
47
44
36
34
25
28
21
21
18
17
13
10
9
8
6
66
51
51
42
40
31
30
28
23
23
18
16
11
11
8
7
: Pew Internet & American Life Project, December 2002 Survey (N = 1,220); November 2004 Survey (N = 537). Margin
of error for comparing the two samples is 4.6%.
*
185
1 2 .. - .. 2550
(video conference)
(on-line diagnosis)
(integrated)
6.
/ 2
186
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- Royal College of GP
- British Medical Association
-
-
-
-
-
- Singapore Medical Council
-
- .
(voluntary)
(mandatory)
187
1 2 .. - .. 2550
Internet
Call
Center
4
2
(Drive)
(Support)
Call Center
188
(.)
(.) (.)
1. Wagner TH, Wagner LS. Who gets second opinions?. Health Affair 1999; 18 (5):137-45.
2. Gray BH. Trust and trustworthy care in the managed care era. Health Affairs 1997; 16:34-49.
3. Rosenthal MS. When to get a second opinion?. The Gynecological Sourcebook. [serial online] 1999 [cited 2005 Sep 1].
Available from : URL : http://my.webmd.com/content/article/3/1680_50683.htm
4. Bloch R, Bloch A. Multidisciplinary second opinion fundamentals. [serial online] 2005 [cited 2005 Sep 5]. Available from
: URL : http://www.blochcancer.org/articles/md2op.html.
5. Cancer Research and Treatment Center: The University of New Mexico. Cancer information. [serial online] 2005 [cited
2005 Oct 12]. Available from: URL : http://cancer.unm.edu/content.aspx?section=cancerinformation&id=23017
6. Mc Carthy EG, Finkel ML, Ruchlin HS. Second opinions on elective surgery. Cornell/New York: Hospital Study; 1891;
1 (8234): 1352-4
7. McSherry CK, Chen PJ, Worner TM, Kupferstein N, Mccarthy ED. Second surgical opinion programs: dead or alive?.
American College of Surgeons 1997; 185: 466-71.
8. Mustafa MK, Bijl M, Gans ROB. What is the value of patient-sought second opinions?. European J Intern Med 2002; 13:
445-7.
9. Althabe F, Belizan JM, Villar J, Alexander S, Bergel E, Romos S. Mandatory second opinion to reduce rates of
unnecessary caesarean sections in Latin America : a cluster randomized controlled trial. Lancet 2004; 363: 1934-40.
10. Newhouse JP, Lindsey P. Do second opinion programs improve outcomes?. Journal of Health Economics 1988; 7: 28588.
11. Gesme D. Managing second opinions [serial online] 2005 [cited 2005 Sept 9]; Available form : URL : http:// 12.3.4.45/
web book/chapter 10.html
12. The National Womens Health Information Center. How to get a second opinion. [online]. 2005 [cited 2005 Sep 5].
Available from: URL: http://www.4woman.gov/tools/SecondOpinion.pdf.
13. Eysenbach G, Sa ER, Diepgen TL. Shopping around the internet today and tomorrow: towards the millennium of
cybermedicine. BMJ 1999; 319: 1294.
14. Taylor H, Leitman R. Health traffic critically dependent on search engines and portals. [serial online] 2001 [cited 2005
Sep 25]; Available from: URL : http://www.harrisinteractive.com/news/newsletters/healthnews/
HI_HealthCareNews2001Vol1_iss13.pdf
15. Fox S. Health information online. [serial online] 2005 May 17 [cited 2005 Sep 25]; Available from: URL :
http://www.pewinternet.org/pdfs/PIP_Healthtopics_May05.pdf
189
1 2 .. - .. 2550
.
. .
.
.
*
190
1. .(1)
.
.
... .
...
.
.
.
2.
(2)
. ...
...
.
(Research Mapping)
191
1 2 .. - .. 2550
.
.
.
.
...
...
.
. .
.
1. .
1 (). :
; 2549.
2. . [ 3 .. 50]; : URL:
http://www.kmi.or.th/autopage/show_all.php.?h=26
192
1 2 .. - .. 2550
*
**
()
*
**
193
1 2 .. - .. 2550
:
, ,
,
Abstract
Key words:
labour, health, strategy, research mapping
194
(1,2)
(3,4)
.
()
(1)
()
(2) (contracts)
() (/) [K1]
(5,6)
1.
195
1 2 .. - .. 2550
2.
3. ( /
)
.
(- )
(SME)
1.
2.
3.
4.
196
.
6
1.
2.
3.
197
1 2 .. - .. 2550
.
(1)
(2)
(3) (FTA) (
/)
(4)
(5)
(6)
198
(7)
. ()
(7,8,9,10)
(8) (
/)
(9)
(10)
(11)
199
1 2 .. - .. 2550
1. . ().
, . : ; 2530.
2. Krongkew M, Chamratrithrong A, Woramontri A. Study of low income household in the Northern region of
Thailand. Nakhon Pathom: Institute for Population and Social Research, Mahidol University; 1983 Report
No.74.
3. . .. 2545. :
; 2547.
4. .
. 2535; 34: 39-41.
5. . :
3 . :
; 2541.
6. , , , , , ,
.
. : ; 2544.
7. . :
. ; 21-22
2540; 3 . : ; 2540.
8. . (
). , . : ; 2546.
9. . :
. 2540; 38: 33-8.
10. . :
(). . . :
; 2543.
200